Puma Biotechnology
PBYI | NASDAQ
$7.34
-$0.43 (-5.53%)
At close: Nov 16, 2026, 4:00 PM ET
$7.20
-$0.14 (-1.91%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-5.53%
(1D)No price chart data available for 1D timeframe.
Rating
48.5
-1.5 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #318/1021 (Top 31%)
Key Statistics
Market Data
Market Cap $379.47M
1D Range
7.27 7.82
52W Range
4.84 11.26
Valuation (TTM)
PE 15.96
PB 3.50
EV/EBITDA 7.32
Valuation (NTM)
Forward PE 20.45
Forward PEG -0.53
Price Target $6.00
Cash Flow
FCF Yield 3.8%
SBC Adj. FCF Yield 3.4%
SBC Impact -11.2%
Margins
Gross Margin 73.6%
Operating Margin 11.3%
FCF Margin 6.2%
Growth (CAGR)
Revenue 3Y | 5Y 0.4% |
-1.5%
Dil EPS 3Y | 5Y 83.3% |
29.0%
FCF 3Y | 5Y 46.0% |
6.8%
Returns
ROA 11.8%
ROE 17.5%
ROIC 14.6%
Financial Health
Net Cash
$108.5M
Current Ratio 3.03
Interest Coverage 12.88
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administ...
Sector Healthcare
Industry Biotechnology
Employees 179
IPO Date Apr 24, 2012
Website www.pumabiotechnology.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 5, 2026
EPS
$0.15
Beat +66.67%
YoY:
-28.57% REV
$54.1M
Miss -5.91%
YoY:
+4.24%Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Hold
Price Target
$6.00
Downside
-18.26%
Buy (0)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove PBYI